Literature DB >> 8547185

Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition.

V Luu-The1, Y Zhang, D Poirier, F Labrie.   

Abstract

Following transfection of types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) cDNAs into transformed embryonal kidney (293) cells, we have characterized the selective directional and inhibitory characteristics of these activities. While homogenates of transfected cells could catalyze interconversion of the substrate and product, in agreement with the general belief on the activity of these enzymes, the same activities measured in intact cells, in order to better reflect the physiological conditions, showed an unidirectional reaction. Types 1 and 3 17 beta-HSD catalyzed the reduction of estrone to estradiol and 4-androstenedione to testosterone, respectively, while type 2 17 beta-HSD catalyzed the oxidative transformation of both testosterone and 17 beta-estradiol to 4-androstenedione and estrone, respectively. In addition, types 1, 2 and 3 17 beta-HSD activities showed different pH optima. While types 1 and 3 showed pH optimum values centered at around 5 and 6, respectively, type 2 17 beta-HSD activity, which preferentially, catalyzes the oxidation reaction, has higher activity at an alkaline pH (8-10). Differences in the optimum incubation temperatures were also observed: type 1 17 beta-HSD shows a relatively high temperature tolerance (55 degrees C). In contrast, type 2 and 3 functioned best at 37 degrees C. Types 1, 2 and 3 17 beta-HSD activities could be also differentiated by their sensitivity toward various specific inhibitors: type 1 was potently inhibited by an estradiol derivative containing a bromo/or iodopropyl group at position 16 alpha. On the other hand a derivative of estrone containing a spiro-gamma-lactone at position 17 showed a potent inhibitory effect on type 2 17 beta-HSD, whereas type 3 was strongly inhibited by 1,4-androstadiene-1,6,17- trione.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547185     DOI: 10.1016/0960-0760(95)00209-x

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  17 in total

Review 1.  Intracrinology-revisited and prostate cancer.

Authors:  Trevor M Penning; Andrea J Detlefsen
Journal:  J Steroid Biochem Mol Biol       Date:  2019-10-12       Impact factor: 4.292

Review 2.  Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.

Authors:  Mirja Rotinen; Joaquín Villar; Ignacio Encío
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

Review 3.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

4.  Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen.

Authors:  Jean-François Couture; Karine Pereira de Jésus-Tran; Anne-Marie Roy; Line Cantin; Pierre-Luc Côté; Pierre Legrand; Van Luu-The; Fernand Labrie; Rock Breton
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

5.  Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.

Authors:  A Gangloff; A Garneau; Y W Huang; F Yang; S X Lin
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

6.  Expression, purification, and characterization of a human recombinant 17beta-hydroxysteroid dehydrogenase type 1 in Escherichia coli.

Authors:  Yi-Hsun Chang; Yuan-Liang Wang; Jain-Yu Lin; Lea-Yea Chuang; Chi-Ching Hwang
Journal:  Mol Biotechnol       Date:  2010-02       Impact factor: 2.695

7.  Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene.

Authors:  Pia Rantakari; Leena Strauss; Riku Kiviranta; Heidi Lagerbohm; Jenni Paviala; Irma Holopainen; Seppo Vainio; Pirjo Pakarinen; Matti Poutanen
Journal:  Mol Endocrinol       Date:  2007-11-29

8.  Androstenedione up-regulation of endometrial aromatase expression via local conversion to estrogen: potential relevance to the pathogenesis of endometriosis.

Authors:  Orhan Bukulmez; Daniel B Hardy; Bruce R Carr; Richard J Auchus; Tannaz Toloubeydokhti; R Ann Word; Carole R Mendelson
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

9.  Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol.

Authors:  Verica Milivojevic; Richard Feinn; Henry R Kranzler; Jonathan Covault
Journal:  Psychopharmacology (Berl)       Date:  2014-05-17       Impact factor: 4.530

10.  Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells.

Authors:  Daniel P Sherbet; Oleg L Guryev; Mahboubeh Papari-Zareei; Dario Mizrachi; Siayareh Rambally; Sharareh Akbar; Richard J Auchus
Journal:  Endocrinology       Date:  2009-06-25       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.